About LenioBio
LenioBio is a Healthcare company based in Dusseldorf (Germany) founded in 2016 by Remberto Martis and Hakon Birgisson. Kits for cell-free eukaryotic protein expression are provided. LenioBio has raised $13.01 million across 7 funding rounds from investors including EIT Food, European Union and Eureka Network. The company has 18 employees. Its chief executive, as recorded, is Remberto Martis. LenioBio offers products and services including ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is LenioBio GmbH.
Company details
LenioBio was founded in 2016 in Dusseldorf, Germany, and operates in the biotechnology sector. Cell-free protein expression kits are developed and supplied, with the ALiCE platform serving as the primary eukaryotic system for handling difficult-to-express proteins. Active energy regeneration is incorporated, along with essential components for protein folding, disulfide bonding, and glycosylation, supporting discovery, development, and production processes.
- Headquarters Dusseldorf, Germany
- Employees 18
- Founders Remberto Martis, Hakon Birgisson
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website leniobio.com
- Social LinkedIn
- Legal Name Leniobio Gmbh
- Total Equity Funding$13.01M (USD)
in 7 rounds
- Latest Funding Round$4.33M (USD), Grant
Jul 2025
- InvestorsEIT Food
& 5 more
- Employee Count18
Products & Services of LenioBio
LenioBio offers a comprehensive portfolio of products and services, including ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression.
Enables rapid and scalable protein production for research.
Offers expert services for challenging protein targets.
Facilitates efficient protein expression in high-throughput setups.
Funding Insights of LenioBio
LenioBio has successfully raised a total of $13.01M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $4.33 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.01M
- Total Rounds 7
- Last Round Grant — $4.33M
- First Round $2.63M
(Aug 2019)
- Investors Count 6
All 7 funding rounds of LenioBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | $4.33M | Grant | – | – | |
| Sep 2023 | Grant | – | – | ||
| May 2022 | $2.9M | Grant | – | – | |
| Feb 2022 | $56,308 | Grant | – | – | |
| Nov 2021 | $13.01M | Series A | – | Bridford Group | – |
| Dec 2019 | $2.62M | Grant | – | – | |
| Aug 2019 | $2.63M | Grant | – | – |
6 investors in total: 6 institutional.
Investors in LenioBio
LenioBio has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Food, European Union and Eureka Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Early-stage tech companies are invested in by Bridford Group. | bridfordgroup.com | London, United Kingdom | ||
Food safety testing services are provided by EIT Food. | 2016 | eitfood.eu | Leuven, Belgium | |
Business management consulting services are offered to clients. | 1985 | eurekanetwork.org | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
EU4Health is focused on promoting health policies across Europe. | eu4health.eu |
Investor details for LenioBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LenioBio
17 people are tracked at LenioBio (7 in leadership, 10 in team); the tracked headcount is 18.
| Name | Role | Group |
|---|---|---|
Remberto Martis | Founder & CEO | Leadership |
Hakon Birgisson | Co-Founder | Leadership |
Daniel Schnitzler | Head Of Production & Plant Operations | Leadership |
Robin Roentgen | Head Of Technical Development | Leadership |
Jonathan Fauerbach (Ph.D. | Head Of Research And Development | Leadership |
Kate Bailey | Head of Marketing and Communications | Leadership |
Hannes Jürgens | Head Of Platform Development | Leadership |
Alexander Dahlmanns, LL.M. | General Counsel | Team |
Maja Lieven (née Rennig) | Team Lead Production | Team |
Charles Williams | Lead Strategic Projects | Team |
Zulfaquar A. Arfi, PhD rer. nat. | Team Lead | Team |
Tessa Strümpfler | Scientist | Team |
Nidhi Shah | Scientist | Team |
Dr. Johannes Gottschalk | Senior Scientist | Team |
Ridhima G. | Senior Scientist | Team |
Yannick Flaskamp | Lead Automation Strategy | Team |
Jo Walter | Strategic Accounrts | Team |
Complete people profiles for LenioBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LenioBio
3 dated milestones of LenioBio across 9 years, from founding to its latest funding, stage changes and deals.
- Founded LenioBio is founded.
- Funding First funding round of $2.6M.
- Funding Latest funding round, Grant, of $4.3M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Leniobio
Complete news archive for LenioBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LenioBio
LenioBio was founded in 2016 and raised its 1st funding round 3 years after it was founded.
LenioBio is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Remberto Martis is the CEO of LenioBio, as recorded in our data. They have also founded this company.
LenioBio is a funded company, having raised a total of $13.01M across 7 funding rounds to date. The company's 1st funding round was a Grant of $2.63M, raised on Aug 2019.
LenioBio has 18 employees.
LenioBio was founded in 2016 in Dusseldorf, Germany, and operates in the biotechnology sector. Cell-free protein expression kits are developed and supplied, with the ALiCE platform serving as the primary eukaryotic system for handling difficult-to-express proteins. Active energy regeneration is incorporated, along with essential components for protein folding, disulfide bonding, and glycosylation, supporting discovery, development, and production processes.
LenioBio offers ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression.
LenioBio has 6 investors. Key investors include EIT Food, European Union, Eureka Network, EIC Fund, and Bridford Group.
LenioBio operates through Leniobio Gmbh.